Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy

Clin Cancer Res. 2020 Feb 1;26(3):758. doi: 10.1158/1078-0432.CCR-19-4091.
No abstract available

Publication types

  • Published Erratum